Currently Viewing:
AMCP 2017
Dr Jennifer Graff on How Payers Make Decisions
August 01, 2017
Laura Topor Discusses Challenges of e-Prescribing Specialty Medications
July 11, 2017
Dr Jacqueline Glover: Financial Knowledge Is Part of Informed Consent
July 10, 2017
Laura Topor Explains the Value of Real-Time Benefit Transactions
June 27, 2017
Dr Jacqueline Glover: Clinicians' Obligations of Justice Regarding Costs of Care
June 24, 2017
Dr Lou Garrison Discusses Challenges of Working With Real-World Data
June 16, 2017
Dr Neil Minkoff Explains How 340B Impacts Pharmacies and Payers Differently
June 15, 2017
Dr Matthew Pickering on Working With Health Plans on Measure Implementation
June 09, 2017
Currently Reading
Laura Topor: Clearing Up Misconceptions About e-Prescribing
June 07, 2017
Dr Richard J. Willke Discusses Challenges of Working With Real-World Data
June 02, 2017
Susan A. Cantrell Explains the Necessity of Pre- and Post-Approval Communications
May 31, 2017
Dr Neil Minkoff Discusses Evolution and Consequences of 340B Programs
May 30, 2017
Dr Doug Hillblom Discusses Legislative Pushes Toward e-Prescribing
May 25, 2017
Dr Matthew Pickering Describes Challenges of New Measure Implementation
May 24, 2017
Dr Aimee Tharaldson Discusses the Orphan Drug Approval Trend
May 22, 2017
Dr Gail Bridges on the Importance of Real-World Results Matching Clinical Trial Outcomes
May 21, 2017
Dr Liz Zhou Discusses Real-World Implications of Toujeo Switching Trial
May 19, 2017
Dr Richard J. Willke on the Value of Real-World Data for Health Plans
May 18, 2017
Dr Lou Garrison on the Discussions Surrounding Outcomes-Based Arrangements
May 17, 2017

Laura Topor: Clearing Up Misconceptions About e-Prescribing

Many people may think e-prescribing refers to the electronic sending of a prescription, but the term actually encompasses a much broader range of communications and transactions, said Laura Topor, president of Granada Health.


Many people may think e-prescribing refers to the electronic sending of a prescription, but the term actually encompasses a much broader range of communications and transactions, said Laura Topor, president of Granada Health.

Transcript (slightly modified)

What misconception about e-prescribing would you like to clear up?

E-prescribing is not just that prescription, but it’s a lot of related transactions, and a lot of messages and ways to communicate prescription information, which could include clinical information about the patient, benefit information, support for REMS-related [risk evaluation and mitigation strategies] transactions, so there’s a lot of activity, there’s a lot of discussion. There are messages we have that aren’t being used, like for the pharmacist to initiate a change request back to the prescriber, or for the prescriber to notify the pharmacy that they’ve discontinued that medication for the patient and the prescription should be cancelled.

So, don’t just think it’s just sending the prescription! It’s broader than that, and I would encourage people to look at ways to get involved, whether it’s through associations, standards bodies, state activity, to see what they can do to drive adoption and identify new ways that we can build messages to support that electronic exchange.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!